Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02656290 · ClinicalTrials.gov registry record · NA
COMMENCE Pulmonary: Clinical Evaluation of Edwards Pericardial Aortic Bioprosthesis (Model 11000A) for Pulmonary Valve Replacement
A NA study, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02656290 is a NA study that has completed, run by Edwards Lifesciences. The registered enrollment target is 26 participants.
The verdict
NCT02656290, a NA study, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The objective of this trial is to assess the safety and effectiveness of the Edwards Pericardial Aortic Bioprosthesis Model 11000A, in the pulmonary position in pediatric and adult subjects five years or older requiring replacement of their native or prosthetic pulmonary valve.
Interventions
- DEVICE Edwards Pericardial Aortic Bioprosthesis Model 11000A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-12 |
| Est. Completion | 2022-11-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02656290
The ClinicalTrials.gov registry entry for NCT02656290 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Edwards Pericardial Aortic Bioprosthesis Model 11000A is the first listed.
NCT02656290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02656290 about?
NCT02656290 is a clinical study titled "COMMENCE Pulmonary: Clinical Evaluation of Edwards Pericardial Aortic Bioprosthesis (Model 11000A) for Pulmonary Valve Replacement". The objective of this trial is to assess the safety and effectiveness of the Edwards Pericardial Aortic Bioprosthesis Model 11000A, in the pulmonary position in pediatric and adult subjects five years or older requiring replacement of their native or prosthetic pulmonary valve.
What is the current status of trial NCT02656290?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2015-12. Estimated completion is 2022-11-28.
What interventions are being tested in trial NCT02656290?
The interventions under investigation include: Edwards Pericardial Aortic Bioprosthesis Model 11000A (DEVICE).
Who is sponsoring clinical trial NCT02656290?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.